Shen, Y.; Singh, J.; Sah, B.; Chen, Z.; Ha, W.; Henzler, C.; Su, T.; Xie, L.; Deng, Y.; Li, G.;
et al. The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers 2022, 14, 4648.
https://doi.org/10.3390/cancers14194648
AMA Style
Shen Y, Singh J, Sah B, Chen Z, Ha W, Henzler C, Su T, Xie L, Deng Y, Li G,
et al. The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers. 2022; 14(19):4648.
https://doi.org/10.3390/cancers14194648
Chicago/Turabian Style
Shen, Yao, Jasvinder Singh, Bindeshwar Sah, Zhongming Chen, Wootae Ha, Christine Henzler, Tao Su, Lillian Xie, Yibin Deng, Gen Li,
and et al. 2022. "The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity" Cancers 14, no. 19: 4648.
https://doi.org/10.3390/cancers14194648
APA Style
Shen, Y., Singh, J., Sah, B., Chen, Z., Ha, W., Henzler, C., Su, T., Xie, L., Deng, Y., Li, G., Guo, H., Hibshoosh, H., & Liu, L.
(2022). The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers, 14(19), 4648.
https://doi.org/10.3390/cancers14194648